Pharmacological Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/05/5703-315-338$7.00
Pharmacol Rev 57:315-338, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toda, N.
Right arrow Articles by Herman, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toda, N.
Right arrow Articles by Herman, A. G.

Article

Gastrointestinal Function Regulation by Nitrergic Efferent Nerves

Noboru Toda and Arnold G. Herman

Toyama Institute for Cardiovascular Pharmacology Research, Azuchi-machi, Chuo-ku, Osaka, Japan (N.T.); and Division of Pharmacology, University of Antwerp, Wilrijk, Belgium (A.G.H.)

Abstract
I. Introduction
II. Nitric Oxide as a Neurotransmitter
    A. Discovery of Nitrergic Nerves
    B. Mechanism of Nitric Oxide Actions
    C. Is the Nitrergic Neurotransmitter Free Radical Nitric Oxide or a Stable Analog of Nitric Oxide?
    D. Cotransmitters Responsible for Nonadrenergic Noncholinergic Inhibitory Responses
    E. In Vivo Studies
III. Nitrergic Innervation in Various Regions
    A. Esophagus
    B. Stomach
    C. Duodenum, Jejunum, Ileum, and Ileocolonic Junction
    D. Colon, Rectum, and Internal Anal Sphincter
    E. Sphincter of Oddi and Gall Bladder
    F. Liver and Pancreas
        1. Liver.
        2. Pancreas.
IV. Secretion and Neurogenic Nitric Oxide
V. Species and Regional Differences in the Nitrergic Regulation
VI. Development and Aging
VII. Prejunctional Regulation
VIII. Gastrointestinal Blood Flow Regulation by Nitrergic Nerves
IX. Pathological Implications
X. Summary
Abstract

Gastrointestinal (GI) smooth muscle responses to stimulation of the nonadrenergic noncholinergic inhibitory nerves have been suggested to be mediated by polypeptides, ATP, or another unidentified neurotransmitter. The discovery of nitric-oxide (NO) synthase inhibitors greatly contributed to our understanding of mechanisms involved in these responses, leading to the novel hypothesis that NO, an inorganic, gaseous molecule, acts as an inhibitory neurotransmitter. The nerves whose transmitter function depends on the NO release are called "nitrergic", and such nerves are recognized to play major roles in the control of smooth muscle tone and motility and of fluid secretion in the GI tract. Endothelium-derived relaxing factor, discovered by Furchgott and Zawadzki, has been identified to be NO that is biosynthesized from L-arginine by the constitutive NO synthase in endothelial cells and neurons. NO as a mediator or transmitter activates soluble guanylyl cyclase and produces cyclic GMP in smooth muscle cells, resulting in relaxation of the vasculature. On the other hand, NO-induced GI smooth muscle relaxation is mediated, not only by cyclic GMP directly or indirectly via hyperpolarization, but also by cyclic GMP-independent mechanisms. Numerous cotransmitters and cross talk of autonomic efferent nerves make the neural control of GI functions complicated. However, the findingsrelated to the nitrergic innervation may provide us a new way of understanding GI tract physiology and pathophysiology and might result in the development of new therapies of GI diseases. This review article covers the discovery of nitrergic nerves, their functional roles, and pathological implications in the GI tract.


Address correspondence to: Dr. Noboru Toda, Toyama Institute for Cardiovascular Pharmacology Research 7-13, 1-Chome, Azuchimachi, Chuo-ku, Osaka 541-0052, Japan. E-mail: n.toda.toyama-bldg{at}orion.ocn.ne.jp




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. L. Kellogg Jr, J. L. Zhao, and Y. Wu
Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo
J. Physiol., February 1, 2008; 586(3): 847 - 857.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Vanneste, I. Dhaese, P. Sips, E. Buys, P. Brouckaert, and R. A. Lefebvre
Gastric motility in soluble guanylate cyclase {alpha}1 knock-out mice
J. Physiol., November 1, 2007; 584(3): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. N. Mutafova-Yambolieva, S. J. Hwang, X. Hao, H. Chen, M. X. Zhu, J. D. Wood, S. M. Ward, and K. M. Sanders
beta-Nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle
PNAS, October 9, 2007; 104(41): 16359 - 16364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Sitmo, M. Rehn, and M. Diener
Stimulation of voltage-dependent Ca2+ channels by NO at rat myenteric neurons
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G886 - G893.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics